GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Symbion Health Ltd (ASX:SY1) » Definitions » EV-to-EBITDA

Symbion Health (ASX:SY1) EV-to-EBITDA : 0.00 (As of Jun. 22, 2024)


View and export this data going back to . Start your Free Trial

What is Symbion Health EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Symbion Health's enterprise value is A$0.00 Mil. Symbion Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2007 was A$209.06 Mil. Therefore, Symbion Health's EV-to-EBITDA for today is 0.00.

The historical rank and industry rank for Symbion Health's EV-to-EBITDA or its related term are showing as below:

ASX:SY1's EV-to-EBITDA is not ranked *
in the Healthcare Plans industry.
Industry Median: 9.385
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-22), Symbion Health's stock price is A$0.00. Symbion Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2007 was A$0.000. Therefore, Symbion Health's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Symbion Health EV-to-EBITDA Historical Data

The historical data trend for Symbion Health's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Symbion Health EV-to-EBITDA Chart

Symbion Health Annual Data
Trend Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Symbion Health Semi-Annual Data
Jun95 Jun96 Jun97 Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Symbion Health's EV-to-EBITDA

For the Healthcare Plans subindustry, Symbion Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Symbion Health's EV-to-EBITDA Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Symbion Health's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Symbion Health's EV-to-EBITDA falls into.



Symbion Health EV-to-EBITDA Calculation

Symbion Health's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/209.059
=0.00

Symbion Health's current Enterprise Value is A$0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Symbion Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2007 was A$209.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Symbion Health  (ASX:SY1) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Symbion Health's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.00/0.000
=N/A

Symbion Health's share price for today is A$0.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Symbion Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2007 was A$0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Symbion Health EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Symbion Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Symbion Health (ASX:SY1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Symbion Group Limited (SYB, formerly Mayne Group Limited) is a healthcare-focused company comprised of 5 divisions: Pathology; Medical Centres; Imaging; Pharmacy Services; and Symbion Consumer.

Symbion Health (ASX:SY1) Headlines

No Headlines